Public Service Announcement - WHNCovid & The Immune System·whn.global·Sep 8, 2024Public Service Announcement - WHN
Hybrid immunity to SARS-CoV-2 arises from serological recall of IgG antibodies distinctly imprinted by infection or vaccinationStudies on Vaccines & Effectiveness·cell.com·Sep 7, 2024Hybrid immunity to SARS-CoV-2 arises from serological recall of IgG antibodies distinctly imprinted by infection or vaccination
UT researchers say they found an antibody that protects against all COVID-19 variants·kxan.com·Sep 6, 2024UT researchers say they found an antibody that protects against all COVID-19 variants
Scientists Develop Game-Changing Needle-Free COVID-19 Intranasal VaccineStudies on Vaccines & Effectiveness·scitechdaily.com·Sep 3, 2024Scientists Develop Game-Changing Needle-Free COVID-19 Intranasal Vaccine
COVID-19 Update: An EUA for Pemivibart (Pemgarda) for Pre-Exposure Prophylaxis | The Medical Letter Inc.Overlooked Treatments·secure.medicalletter.org·Sep 1, 2024COVID-19 Update: An EUA for Pemivibart (Pemgarda) for Pre-Exposure Prophylaxis | The Medical Letter Inc.
Monoclonal Antibody Authorized to Protect At-Risk People From COVID-19Overlooked Treatments·jamanetwork.com·Sep 1, 2024Monoclonal Antibody Authorized to Protect At-Risk People From COVID-19
Sofosbuvir and daclatasvir for the treatment of COVID-19 outpatients: a double-blind, randomized controlled trialOverlooked Treatments·ncbi.nlm.nih.gov·Sep 1, 2024Sofosbuvir and daclatasvir for the treatment of COVID-19 outpatients: a double-blind, randomized controlled trial
Efficacy and safety of the sofosbuvir/velpatasvir combination for the treatment of patients with early mild to moderate COVID-19Overlooked Treatments·nature.com·Sep 1, 2024Efficacy and safety of the sofosbuvir/velpatasvir combination for the treatment of patients with early mild to moderate COVID-19
NasalCrom for Neuroinflammation?Long Covid·pharmd.substack.com·Sep 1, 2024NasalCrom for Neuroinflammation?
Study: Long COVID affects 8% of those with COVID-19, is more common in womenLong Covid·cidrap.umn.edu·Sep 1, 2024Study: Long COVID affects 8% of those with COVID-19, is more common in women
Plasma taurine level is linked to symptom burden and clinical outcomes in post-COVID conditionOverlooked Treatments·ncbi.nlm.nih.gov·Sep 1, 2024Plasma taurine level is linked to symptom burden and clinical outcomes in post-COVID condition
Researchers identify amino acid that may play a key role for predicting and treating long COVIDOverlooked Treatments·ualberta.ca·Sep 1, 2024Researchers identify amino acid that may play a key role for predicting and treating long COVID
Safety and efficacy of low dose naltrexone in a long covid cohort; an interventional pre-post studyOverlooked Treatments·ncbi.nlm.nih.gov·Sep 1, 2024Safety and efficacy of low dose naltrexone in a long covid cohort; an interventional pre-post study
From a Grassroots Survey to Long Covid Treatment TrialsOverlooked Treatments·undark.org·Sep 1, 2024From a Grassroots Survey to Long Covid Treatment Trials
Statin Use in Relation to COVID-19 and Other Respiratory Infections: Muscle and Other ConsiderationsOverlooked Treatments·ncbi.nlm.nih.gov·Sep 1, 2024Statin Use in Relation to COVID-19 and Other Respiratory Infections: Muscle and Other Considerations
Americans Don’t Get to Have the Best New COVID DrugOverlooked Treatments·theatlantic.com·Sep 1, 2024Americans Don’t Get to Have the Best New COVID Drug
Further patients benefit from drug against Long COVIDOverlooked Treatments·fau.eu·Sep 1, 2024Further patients benefit from drug against Long COVID
Long COVID: Study Says Synbiotic Drug That Alters Gut Microbiome Relieves Multiple SymptomsOverlooked Treatments·medicaldaily.com·Sep 1, 2024Long COVID: Study Says Synbiotic Drug That Alters Gut Microbiome Relieves Multiple Symptoms
NIH Launches Trials for Long COVID Treatment BreakthroughsOverlooked Treatments·autoimmuneinstitute.org·Sep 1, 2024NIH Launches Trials for Long COVID Treatment Breakthroughs
Intravenous immunoglobulin as a potential treatment for long COVIDOverlooked Treatments·tandfonline.com·Sep 1, 2024Intravenous immunoglobulin as a potential treatment for long COVID
Large Review Suggests IVIG is Effective for Neurological Diseases Following COVID-19 InfectionOverlooked Treatments·pharmacytimes.com·Sep 1, 2024Large Review Suggests IVIG is Effective for Neurological Diseases Following COVID-19 Infection
Efficacy of intravenous immunoglobulin (IVIg) on COVID-19-related neurological disorders over the last 2 years: an up-to-date narrative review - PubMedOverlooked Treatments·pubmed.ncbi.nlm.nih.gov·Sep 1, 2024Efficacy of intravenous immunoglobulin (IVIg) on COVID-19-related neurological disorders over the last 2 years: an up-to-date narrative review - PubMed
Long-term high-dose immunoglobulin successfully treats Long COVID patients with pulmonary, neurologic, and cardiologic symptomsOverlooked Treatments·ncbi.nlm.nih.gov·Sep 1, 2024Long-term high-dose immunoglobulin successfully treats Long COVID patients with pulmonary, neurologic, and cardiologic symptoms
Clinical and CSF single-cell profiling of post-COVID-19 cognitive impairmentOverlooked Treatments·cell.com·Sep 1, 2024Clinical and CSF single-cell profiling of post-COVID-19 cognitive impairment
Interferon-λ treatment accelerates SARS-CoV-2 clearance despite age-related delays in the induction of T cell immunityOverlooked Treatments·nature.com·Sep 1, 2024Interferon-λ treatment accelerates SARS-CoV-2 clearance despite age-related delays in the induction of T cell immunity
Long COVID Looks Like Acute Infection in the BrainOverlooked Treatments·psychologytoday.com·Sep 1, 2024Long COVID Looks Like Acute Infection in the Brain
Frontiers | Corrigendum: Case Series: Maraviroc and pravastatin as a therapeutic option to treat long COVID/Post-acute sequalae of COVID (PASC)Overlooked Treatments·frontiersin.org·Sep 1, 2024Frontiers | Corrigendum: Case Series: Maraviroc and pravastatin as a therapeutic option to treat long COVID/Post-acute sequalae of COVID (PASC)
Study Details | Antiviral Clinical Trial for Long Covid-19 | ClinicalTrials.govOverlooked Treatments·clinicaltrials.gov·Sep 1, 2024Study Details | Antiviral Clinical Trial for Long Covid-19 | ClinicalTrials.gov
RECOVER Clinical Trials | HomeOverlooked Treatments·trials.recovercovid.org·Sep 1, 2024RECOVER Clinical Trials | Home
